In the Pharma industry, data integrity is essential for effective decision-making, regulatory compliance, and business operations. Chryselys’ Data Anomaly Detection capability provides a robust framework to identify, analyze, and correct anomalies across both master and transactional
datasets. By integrating AI-driven anomaly detection with statistical methodologies, we help Pharma companies eliminate data inconsistencies, reduce compliance risks, and enhance overall data quality.